drugset / Trial / NCT01380353

Test Uniformity of Transdermal Drug Delivery to Breast Using Diclofenac Epolamine

NCT01380353

Phase 0 Completed 30 enrolled Northwestern University
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to look for ways to improve breast cancer treatment by giving breast cancer drugs through the skin of the breast. The drug used in this study is a diclofenac epolamine patch and is a nonsteroid anti-inflammatory pain reliever. The drug amount that gathers in the breast, after application of a patch to the skin of the breast, will be measured and compared to the amount that is found in the breast when the patch is applied to the skin of the belly.

Timeline

Start
2011-06
Primary completion
2012-11-12
Completion
2012-11-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Diclofenac epolamine Unknown 1.3 % Other

Indications